OTC · Medical - Devices

Manhattan Scientifics, Inc. (MHTX) Stock

$0.00 OTC: MHTX Healthcare

Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States.

Valuation

MetricValue
Price$0.00
Market Cap$55928
P/E Ratio-0.05
P/B Ratio-0.03
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE50.00%
ROA-368.67%
ROCE39.01%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.03

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-1.0M$-1.0M
Net Profit$-1.0M$4.0M$-4.0M$-3.0M$-1.0M
EPS$0.00$0.01$-0.01$0.00$0.00
Op Margin-1056.7%-1350.0%-1374.0%-1358.0%—

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$2.0M$7.0M$3.0M$1.0M$0
Total Liabilities$3.0M$2.0M$2.0M$3.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.04
FCF Yield-339.72%
Quick Ratio0.03
Interest Coverage—
Return 1Y-80.00%
Return 3Y-99.37%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOIFBiome Grow Inc. $0.00 — -0.01 $56208 0.00%
CBGLCannabis Global Inc. $0.00 — -3.40 $56821 0.00%
IMMBImmunotech Laboratories, Inc. $0.00 — -0.22 $114993 0.00%
INSDInstadose Pharma Corp. $0.00 — -0.02 $53193 0.00%
IPAHInterpharm Holdings, Inc. $0.00 — — $660 0.00%

About Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.

Manhattan Scientifics, Inc. (MHTX) stock trades at $0.00 with a market capitalization of $55928. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.05, reflecting a net loss over the last twelve months, a negative price-to-book of -0.03, reflecting negative shareholders' equity, price-to-sales of 0.00.

On profitability, Manhattan Scientifics, Inc. generates a return on equity (ROE) of 50.00%, above the typical market range of roughly 12-15%, return on capital employed of 39.01%.

Official website: www.mhtx.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.